Abiopharma

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025

Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors

Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025

Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

📋 Finn Patrick John (Officer) plans to sell 2K shares of Twist Bioscience Corp (at $30.87 each, total $69K) Filed: Oct 23, 2025 | ID: 006533

(10% Negative) UTAH MEDICAL PRODUCTS, INC. (UTMD) Reports Q4 2025 Financial Results

Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL

Ionis ranked #2 Top Employer by Science magazine, recognizing industry-leading scientific innovation and company culture